Health & WellnessTech
SciTech Development, L.L.C.
Advancing Cancer Treatment Through Safer Drug Delivery
Grosse Pointe Farms,
MI
Investment type:
Equity
(Units)
Target raise:
$9,999
- $5,000,000
Minimum investment:
$275
$275
End date:
Apr 29, 2022
Apr 29, 2022
ended
Our Story
SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthrough cancer treatments. We have developed a powerful, new Drug Delivery Platform (SDP) that will revolutionize how safe and promising, yet challenged drugs, can be delivered to kill cancer. SciTech has developed our first, patented drug, ST-001-nanoFenretinide that combines SDP and the drug fenretinide as a broadly applicable anticancer drug. SciTechs innovations will impact our mission to develop cost-effective therapeutics that deliver transformative clinical outcomes. SciTech Development is in the pre-revenue clinical stage of development.